Evidence map›Paper›PMID 40087182›Full record

ArticleSurgical endoscopy2025

Laparoscopic versus open secondary hepatectomy treating postoperative regional recurrent hepatolithiasis: a multicenter real-world study.

Dihang Wu, Long Huang, Chengyu Liao, Ge Li, Junyong Pan, Liang Wang, Zhiyun Chen, Ye Lin, Chun Zhang, Congren Wang and 6 more

Abstract readMulticenter StudyComparative Study
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Dihang Wu *Shengli Clinical Medical College of Fujian Medical University Fuzhou, Fuzhou, China.
Long Huang *Shengli Clinical Medical College of Fujian Medical University Fuzhou, Fuzhou, China.
Chengyu Liao *Shengli Clinical Medical College of Fujian Medical University Fuzhou, Fuzhou, China.
Ge LiFujian Medical University Union Hospital, Fuzhou, China.
Junyong PanThe Second Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Liang WangThe First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Zhiyun ChenThe First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Ye LinGuangdong People's Hospital, Guangzhou, China.
Chun ZhangFujian Medical University Affiliated Mindong Hospital, Ningde, China.
Congren WangFujian Medical University Affiliated Quanzhou First Hospital, Quanzhou, China.
Yufeng ChenFujian Medical University Affiliated Zhangzhou Hospital, Zhangzhou, China.
Tiansheng LinShengli Clinical Medical College of Fujian Medical University Fuzhou, Fuzhou, China.
Jianlin LaiShengli Clinical Medical College of Fujian Medical University Fuzhou, Fuzhou, China.
Yanling ChenFujian Medical University Union Hospital, Fuzhou, China.
Yifeng TianShengli Clinical Medical College of Fujian Medical University Fuzhou, Fuzhou, China. tianyifeng@fjmu.edu.cn.
Shi ChenShengli Clinical Medical College of Fujian Medical University Fuzhou, Fuzhou, China. wawljwalj@163.com.ORCID http://orcid.org/0000-0002-8207-7479

Funding

Fujian Provincial Health Technology Project 2021GGA006Fujian Research and Training Grants for Young and Middle-aged Leaders in Healthcare No.2021(60)Natural Science Foundation of Fujian Province 2022J05212
6 · The paper itself

Abstract

backgroundHepatectomy is the primary treatment for regional hepatolithiasis, but recurrence rates range from 10 to 20%, often necessitating repeat surgery. Although laparoscopic hepatectomy has been widely adopted for recurrent hepatocellular carcinoma, its use in recurrent hepatolithiasis remains limited due to technical challenges, including severe adhesions, anatomical distortions, and increased risks of complications. No large-scale study has compared laparoscopic and open repeat hepatectomy for recurrent regional hepatolithiasis.

methodsThis multicenter retrospective study included 913 patients from nine high-volume centers in southeastern China between May 2014 and 2023. Patients were divided into laparoscopic (n = 338) and open surgery (n = 575) groups. Propensity score matching was used to balance baseline characteristics. Primary outcomes included stone clearance rates and textbook outcomes (TO), a composite measure assessing final stone clearance, hospital stay, bile leakage, major complications, and 30-day readmissions. Secondary outcomes included perioperative metrics, complication rates, and recurrence-free survival.

resultsAfter PSM, laparoscopic surgery demonstrated comparable immediate stone clearance rates (81.07% vs. 78.40%, p = 0.386) but significantly better TO rates (61.54% vs. 46.09%, p < 0.001) to the open surgery group. The laparoscopic group had reduced blood loss (p = 0.016), shorter hospital stays (p < 0.001), faster recovery of bowel function (p < 0.001), and fewer major complications (13.91% vs. 23.08%, p = 0.003). Recurrence rates were similar between groups during a median follow-up of 36 months. Hepatic lobe atrophy and biliary strictures were identified as independent risk factors for reduced stone clearance.

conclusionLaparoscopic repeat hepatectomy offers comparable stone clearance rates to open surgery while providing significant advantages in perioperative outcomes, including reduced complications and faster recovery. These findings suggest laparoscopic surgery is a feasible and effective option for recurrent regional hepatolithiasis.

Indexed as

HepatectomyLaparoscopyLithiasisLiver DiseasesAdultAgedChinaFemaleHumansLength of StayMaleMiddle AgedPostoperative ComplicationsPropensity ScoreRecurrenceReoperationLaparoscopic hepatectomyRecurrent hepatolithiasisSecondary hepatectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.